Piper vs Zera Health
Two flat nationwide rates, seventeen dollars apart, with different amounts of detail.
Piper
Editorial
$146/mo
One published figure per molecule, with no membership charge beside either: $135 for compounded semaglutide and $199 for compounded tirzepatide. Each buys a four-week dosage rather than a calendar month, so thirteen fills land in a year. Coverage is stated across 50 states and the rate is stated to hold at every dose.
Pick it for: Buyers who want the format of each line spelled out
Zera Health
Editorial
$129/mo
Three lines with the dosing form stated on each. The $129 semaglutide injection is described by Zera as a low-dose weekly line, the $169 oral is a daily dissolving tablet, and tirzepatide is $199 weekly. That qualifier travels with the figure: a low-dose rate is not priced against a standard starting dose. Zera states each rate holds at every dose. Coverage is stated across 50 states.
Pick it for: Buyers who prefer a shorter menu at a similar figure
Our verdict
Zera Health opens at $129 and names the dosing form on each line; Piper opens at $146 with two lines priced. Both state their rates hold.
What actually separates them
Piper and Zera Health state different things about published price. Everything else they publish, they publish the same way.
Piper costs $17 more than Zera Health — 13% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,548 at Zera Health against $1,752 at Piper — a difference of $204.
| Piper | Zera Health | |
|---|---|---|
| Published price | $146/mo | $129/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.